Sign in
Enrolling by invitationNo phase

Effects of Wild Thyme Extract on Overweight and Obesity

Key facts

Who runs it
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Where
Spain1 site in 1 countryChoose a country to see its sites
Trial code
Status
Enrolling by invitation
People taking part
53 people, planned
Started
17 Sept 2026
Expected to end
17 Sept 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Wild Thyme extract
  • Placebo
Record updated
16 November 2026

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Body mass index (BMI) ≥25.0 kg/m² at screening
  • Participants with overweight (BMI 25.0-29.9 kg/m²) or obesity (BMI ≥30.0 kg/m²)
  • Stable body weight during the predefined period before screening
  • Willingness to maintain usual dietary and physical activity habits throughout the intervention period
  • Ability and willingness to provide fecal samples at the predefined study time points
  • Ability to comply with study procedures and intervention requirements
  • Ability to understand the study procedures and provide written informed consent

Who cannot take part

  • Presence of established or clinically unstable cardiovascular disease. 3. Pregnancy or breastfeeding. 4. Clinical diagnosis of inflammatory bowel disease. 5. Clinical diagnosis of celiac disease. 6. Major gastrointestinal disease that may interfere with study outcomes. 7. Previous bariatric surgery
  • Use of investigational drugs within the predefined washout period
  • Use of probiotics, prebiotics, synbiotics, or other microbiome-modulating supplements during the predefined washout period
  • Known allergy or hypersensitivity to Thymus species or any component of the study product or placebo
  • Any medical condition that, in the investigator's opinion, may interfere with participant safety, study compliance, interpretation of results, or completion of study procedures
  • Current participation in another interventional clinical trial

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Overweight and obesity are characterized by excessive or abnormal adiposity and are associated with an increased risk of metabolic dysfunction, chronic low-grade inflammation, and several chronic diseases. While overweight is not classified as a disease in itself, it represents an early stage in the continuum of excess adiposity and is associated with an increased risk of progression to obesity and the development of obesity-related metabolic complications. Therefore, early intervention during the overweight stage may represent a critical opportunity to prevent or delay disease progression to obesity. Increasing evidence indicates that the gut microbiome plays an important role in metabolic homeostasis and may contribute to the development and progression of overweight and obesity through interactions with host metabolism, intestinal barrier function, immune responses, and microbial-derived metabolites.

Read full original descriptionShow less

This randomized, double-blind, placebo-controlled clinical trial will evaluate whether daily supplementation with a chemically characterized wild thyme (Thymus serpyllum L.) extract for 12 weeks can improve body weight and obesity- and overweight-related anthropometric, metabolic, and inflammatory parameters and modulate the gut microbiome in adults with overweight or obesity. Participants will be randomly assigned in a 1:1 ratio to receive either wild thyme extract or a matching placebo. The primary objective is to evaluate the effect of the intervention on change in body weight after 12 weeks of treatment. Secondary objectives include evaluating changes in body composition, waist circumference, metabolic parameters, inflammatory biomarkers, and intestinal microbiome composition. The study will also investigate whether baseline gut microbiome characteristics or changes in the gut microbiome are associated with the clinical response to treatment, with the aim of identifying potential microbiome-based biomarkers of response. By targeting individuals across the spectrum from overweight to obesity, this study aims to explore whether early intervention in excess adiposity may provide an opportunity to improve metabolic health and potentially reduce progression toward more severe obesity and associated complications.

The 2 groups in the trial

  • Wild Thyme ExtractTreatment being tested

    Participants assigned to the experimental arm will receive a chemically characterized wild thyme (Thymus serpyllum L.) extract at a total daily dose of 600 mg, administered orally in capsule form once daily for 12 weeks.

  • PlaceboPlacebo, for comparison

    Participants assigned to the placebo arm will receive matching placebo capsules containing microcrystalline cellulose at an equivalent daily administration schedule for 12 weeks.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Randomized, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Effects of a Chemically Characterized Wild Thyme (Thymus Serpyllum L.) Extract on Body Weight, Metabolic Health, Inflammation, and the Gut Microbiome in Adults With Overweight or Obesity
Fit questions
Built from NCT07939425, who can take part
Record updated
16 November 2026